The Global Ureteral Stents Market in 2026 is moving toward a "patient-comfort-first" model. While traditionally seen as a purely functional drainage tool, the market is now dominated by stents featuring anti-encrustation coatings and biodegradable materials that eliminate the need for a secondary removal procedure. With the surge in minimally invasive urological surgeries and the "stone-belt" expanding globally due to dietary shifts, ureteral stents have become a high-volume essential in modern surgical suites.
Market Valuation & Forecast (2025–2036)
The Global Ureteral Stents Market was valued at approximately USD 615.4 Million in 2025. It is projected to reach USD 1.25 Billion by the year 2036, growing at a CAGR of 6.7% globally.
Segments Analysis
Segmentation has evolved from simple length-based categories to material-science-driven classifications.
| Category | Key Segments |
| By Type | Double Pigtail (Double J) (Dominant - 75%+ share), Multiloop, Open/Closed End, Single Pigtail. |
| By Material | Polymer (Polyurethane, Silicone, C-Flex), Metallic (Nitinol, Stainless Steel), Bioresorbable/Biodegradable (Fastest growing). |
| By Coating | Hydrophilic (Standard), Anti-microbial/Anti-encrustation, Drug-Eluting (Heparin/Antiprotozoal). |
| By Application | Kidney Stones (Urolithiasis), Kidney Transplantation, Tumors/Malignancies, Strictures & Obstructions. |
| By End-User | Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Urology Clinics. |
Regional Analysis
-
North America: The largest market (~38% share). High healthcare expenditure and early adoption of 3D-printed personalized stents keep the U.S. at the forefront of the market.
-
Asia-Pacific: The fastest-growing region (CAGR ~8.1%). Driven by a massive increase in kidney stone cases in China and India, alongside the rapid expansion of medical tourism for affordable stone management.
-
Europe: Focuses on regulatory compliance (EU MDR) and value-based procurement. Strong demand exists for Metallic Stents used in chronic malignant obstructions across Germany and France.
-
LAMEA: Increasing investment in specialized urology centers in the GCC countries and Brazil is fueling the demand for premium, long-term indwelling stents.
Top Key Players
-
Market Leaders: Boston Scientific Corporation (LithoFlex™), Cook Medical, Becton, Dickinson and Company (BD/Bard), Coloplast A/S.
-
Global Specialists: Olympus Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Applied Medical.
-
Innovation Challengers: Allium Medical, Amecath, Medi-Globe Group, Ureteral Stent Co. (Relief™), Vivasure Medical, ProSurg Inc.
Porter’s Five Forces
-
Bargaining Power of Buyers (High): Large hospital GPOs (Group Purchasing Organizations) have significant leverage, forcing manufacturers to bundle stents with wider endourology portfolios (lasers, baskets).
-
Threat of New Entrants (Low-Moderate): While the market is fragmented, the R&D required for Bioresorbable materials acts as a high entry barrier.
-
Bargaining Power of Suppliers (Moderate): Suppliers of specialized medical-grade Nitinol and high-end silicone maintain steady power due to rigorous certification standards.
-
Threat of Substitutes (Low): Nephrostomy tubes are an alternative but are far more invasive; stents remain the gold standard for internal drainage.
-
Competitive Rivalry (Extreme): Competitors are in a "feature war" to reduce the dreaded "stent syndrome" (pain and urgency).
SWOT Analysis
-
Strengths: High procedural volume; indispensable for post-ureteroscopy care; well-established reimbursement codes.
-
Weaknesses: High rates of patient discomfort; risk of stent-associated UTIs and encrustation.
-
Opportunities: Smart Stents with integrated sensors for pressure monitoring; expansion of Single-Use Lithotripsy kits including the stent.
-
Threats: Shift toward "Stent-less" ureteroscopy in very specific, simple stone cases; pricing pressure from regional manufacturers in Asia.
Trend Analysis 2026
-
Bioresorbable Stents: The "Holy Grail" of urology—stents that dissolve naturally after 4–6 weeks, sparing the patient an uncomfortable cystoscopy for removal.
-
3D Printing/Personalization: Custom-sized stents tailored to a patient's unique ureteral length and diameter to minimize "reflux" and bladder irritation.
-
AI-Guided Sizing: Software that analyzes CT scans to recommend the exact stent size, reducing the "one-size-fits-all" approach that causes discomfort.
Drivers & Challenges
-
Driver: The Obesity & Diabetes Epidemic: These conditions are directly linked to higher kidney stone formation rates.
-
Driver: Outpatient Shift: Increasing number of stent placements in ASCs, requiring easier-to-use delivery systems.
-
Challenge: Stent Encrustation: For long-term patients (oncology), the mineralization of the stent can make removal extremely difficult and dangerous.
-
Challenge: Healthcare "Green" Regulations: Growing pressure to find eco-friendly disposal or manufacturing methods for high-volume disposables.
Value Chain Analysis
-
Material Sourcing: Precision Nitinol and biocompatible polymers (Polyurethane).
-
Advanced Extrusion: Creating the "Double J" coil and precision side-holes for optimal flow.
-
Coating Technology: Applying hydrophilic or drug-eluting layers to the surface.
-
Logistics: Strategic distribution to Hospital Central Sterile Supply Departments (CSSD).
Quick Recommendations for Stakeholders
-
For Manufacturers: Focus on Suture-Retrieval Designs. Stents with a string for patient-led removal are gaining popularity for short-term use, reducing clinic follow-up costs.
-
For Urologists: Transition to Digital Stent Trackers. Using apps or EHR-integrated trackers prevents the "Forgotten Stent" complication, which is a major source of medical malpractice.
-
For Investors: Focus on the Bioresorbable Segment. Companies that solve the "unpredictable dissolution rate" will likely be the next targets for major acquisition.
1. Market Overview of Ureteral Stents 1.1 Ureteral Stents Market Overview 1.1.1 Ureteral Stents Product Scope 1.1.2 Market Status and Outlook 1.2 Ureteral Stents Market Size by Regions: 1.3 Ureteral Stents Historic Market Size by Regions 1.4 Ureteral Stents Forecasted Market Size by Regions 1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth 1.5.1 North America 1.5.2 East Asia 1.5.3 Europe 1.5.4 South Asia 1.5.5 Southeast Asia 1.5.6 Middle East 1.5.7 Africa 1.5.8 Oceania 1.5.9 South America 1.5.10 Rest of the World 1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.6.2 Covid-19 Impact: Commodity Prices Indices 1.6.3 Covid-19 Impact: Global Major Government Policy 2. Covid-19 Impact Ureteral Stents Sales Market by Type 2.1 Global Ureteral Stents Historic Market Size by Type 2.2 Global Ureteral Stents Forecasted Market Size by Type 2.3 <10cm 2.4 10cm-20cm 2.5 21cm-30cm 2.6 >30cm 3. Covid-19 Impact Ureteral Stents Sales Market by Application 3.1 Global Ureteral Stents Historic Market Size by Application 3.2 Global Ureteral Stents Forecasted Market Size by Application 3.3 Hospital 3.4 Clinic 4. Covid-19 Impact Market Competition by Manufacturers 4.1 Global Ureteral Stents Production Capacity Market Share by Manufacturers 4.2 Global Ureteral Stents Revenue Market Share by Manufacturers 4.3 Global Ureteral Stents Average Price by Manufacturers 5. Company Profiles and Key Figures in Ureteral Stents Business 5.1 B. Braun Melsungen AG 5.1.1 B. Braun Melsungen AG Company Profile 5.1.2 B. Braun Melsungen AG Ureteral Stents Product Specification 5.1.3 B. Braun Melsungen AG Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.2 Bard Medical 5.2.1 Bard Medical Company Profile 5.2.2 Bard Medical Ureteral Stents Product Specification 5.2.3 Bard Medical Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.3 Coloplast 5.3.1 Coloplast Company Profile 5.3.2 Coloplast Ureteral Stents Product Specification 5.3.3 Coloplast Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.4 Boston Scientific 5.4.1 Boston Scientific Company Profile 5.4.2 Boston Scientific Ureteral Stents Product Specification 5.4.3 Boston Scientific Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.5 Applied Medical 5.5.1 Applied Medical Company Profile 5.5.2 Applied Medical Ureteral Stents Product Specification 5.5.3 Applied Medical Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.6 Allium Medical 5.6.1 Allium Medical Company Profile 5.6.2 Allium Medical Ureteral Stents Product Specification 5.6.3 Allium Medical Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.7 Amecath 5.7.1 Amecath Company Profile 5.7.2 Amecath Ureteral Stents Product Specification 5.7.3 Amecath Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.8 Gohar Shafa Co 5.8.1 Gohar Shafa Co Company Profile 5.8.2 Gohar Shafa Co Ureteral Stents Product Specification 5.8.3 Gohar Shafa Co Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.9 Olympus 5.9.1 Olympus Company Profile 5.9.2 Olympus Ureteral Stents Product Specification 5.9.3 Olympus Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.10 ProSurg 5.10.1 ProSurg Company Profile 5.10.2 ProSurg Ureteral Stents Product Specification 5.10.3 ProSurg Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.11 Medi-Globe Group 5.11.1 Medi-Globe Group Company Profile 5.11.2 Medi-Globe Group Ureteral Stents Product Specification 5.11.3 Medi-Globe Group Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 5.12 Teleflex Incorporated 5.12.1 Teleflex Incorporated Company Profile 5.12.2 Teleflex Incorporated Ureteral Stents Product Specification 5.12.3 Teleflex Incorporated Ureteral Stents Production Capacity, Revenue, Price and Gross Margin 6. North America 6.1 North America Ureteral Stents Market Size 6.2 North America Ureteral Stents Key Players in North America 6.3 North America Ureteral Stents Market Size by Type 6.4 North America Ureteral Stents Market Size by Application 7. East Asia 7.1 East Asia Ureteral Stents Market Size 7.2 East Asia Ureteral Stents Key Players in North America 7.3 East Asia Ureteral Stents Market Size by Type 7.4 East Asia Ureteral Stents Market Size by Application 8. Europe 8.1 Europe Ureteral Stents Market Size 8.2 Europe Ureteral Stents Key Players in North America 8.3 Europe Ureteral Stents Market Size by Type 8.4 Europe Ureteral Stents Market Size by Application 9. South Asia 9.1 South Asia Ureteral Stents Market Size 9.2 South Asia Ureteral Stents Key Players in North America 9.3 South Asia Ureteral Stents Market Size by Type 9.4 South Asia Ureteral Stents Market Size by Application 10. Southeast Asia 10.1 Southeast Asia Ureteral Stents Market Size 10.2 Southeast Asia Ureteral Stents Key Players in North America 10.3 Southeast Asia Ureteral Stents Market Size by Type 10.4 Southeast Asia Ureteral Stents Market Size by Application 11. Middle East 11.1 Middle East Ureteral Stents Market Size 11.2 Middle East Ureteral Stents Key Players in North America 11.3 Middle East Ureteral Stents Market Size by Type 11.4 Middle East Ureteral Stents Market Size by Application 12. Africa 12.1 Africa Ureteral Stents Market Size 12.2 Africa Ureteral Stents Key Players in North America 12.3 Africa Ureteral Stents Market Size by Type 12.4 Africa Ureteral Stents Market Size by Application 13. Oceania 13.1 Oceania Ureteral Stents Market Size 13.2 Oceania Ureteral Stents Key Players in North America 13.3 Oceania Ureteral Stents Market Size by Type 13.4 Oceania Ureteral Stents Market Size by Application 14. South America 14.1 South America Ureteral Stents Market Size 14.2 South America Ureteral Stents Key Players in North America 14.3 South America Ureteral Stents Market Size by Type 14.4 South America Ureteral Stents Market Size by Application 15. Rest of the World 15.1 Rest of the World Ureteral Stents Market Size 15.2 Rest of the World Ureteral Stents Key Players in North America 15.3 Rest of the World Ureteral Stents Market Size by Type 15.4 Rest of the World Ureteral Stents Market Size by Application 16 Ureteral Stents Market Dynamics 16.1 Covid-19 Impact Market Top Trends 16.2 Covid-19 Impact Market Drivers 16.3 Covid-19 Impact Market Challenges 16.4 Porter’s Five Forces Analysis 18 Regulatory Information 17 Analyst's Viewpoints/Conclusions 18 Appendix 18.1 Research Methodology 18.1.1 Methodology/Research Approach 18.1.2 Data Source 18.2 Disclaimer
Segments Analysis
Segmentation has evolved from simple length-based categories to material-science-driven classifications.
| Category | Key Segments |
| By Type | Double Pigtail (Double J) (Dominant - 75%+ share), Multiloop, Open/Closed End, Single Pigtail. |
| By Material | Polymer (Polyurethane, Silicone, C-Flex), Metallic (Nitinol, Stainless Steel), Bioresorbable/Biodegradable (Fastest growing). |
| By Coating | Hydrophilic (Standard), Anti-microbial/Anti-encrustation, Drug-Eluting (Heparin/Antiprotozoal). |
| By Application | Kidney Stones (Urolithiasis), Kidney Transplantation, Tumors/Malignancies, Strictures & Obstructions. |
| By End-User | Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Urology Clinics. |
Regional Analysis
-
North America: The largest market (~38% share). High healthcare expenditure and early adoption of 3D-printed personalized stents keep the U.S. at the forefront of the market.
-
Asia-Pacific: The fastest-growing region (CAGR ~8.1%). Driven by a massive increase in kidney stone cases in China and India, alongside the rapid expansion of medical tourism for affordable stone management.
-
Europe: Focuses on regulatory compliance (EU MDR) and value-based procurement. Strong demand exists for Metallic Stents used in chronic malignant obstructions across Germany and France.
-
LAMEA: Increasing investment in specialized urology centers in the GCC countries and Brazil is fueling the demand for premium, long-term indwelling stents.
Top Key Players
-
Market Leaders: Boston Scientific Corporation (LithoFlex™), Cook Medical, Becton, Dickinson and Company (BD/Bard), Coloplast A/S.
-
Global Specialists: Olympus Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Applied Medical.
-
Innovation Challengers: Allium Medical, Amecath, Medi-Globe Group, Ureteral Stent Co. (Relief™), Vivasure Medical, ProSurg Inc.
